{"status":"OK","data":{"advertisement":{"id":297800,"title":"Zakup i dostawa us\u0142ugi / Purchase and delivery of service","partial_offer_allowed":false,"publication_date":"2025-04-24","submission_deadline":"2025-05-05 23:59:59","planned_sign_date":null,"supplementary_orders":null,"terms_of_contract_change":null,"created_at":"2025-04-24 14:40:14","modified_at":"2025-05-06 00:00:09","contact_persons":[{"id":206,"forename":"Gra\u017cyna","surname":"G\u00f3ra","phone_number":"723170234","email":"grazyna.gora@rezonbio.com","created_by":null,"created_at":"2026-10-26 14:06:10","modified_at":"2026-10-26 14:06:10","modified_by":null}],"orders":[{"id":483314,"estimated_value":null,"order_items":[{"id":545018,"description":"Analiza aktywno\u015bci ADCC, ADCP i CDC dla przeciwcia\u0142a monoklonalnego \u2013 potwierdzenie braku funkcji Fc efektorowych.\nCelem tego zam\u00f3wienia jest opracowanie nowoczesnych metod analitycznych do oceny wskazanych aktywno\u015bci, z odpowiednio dobranymi kontrolami pozytywnymi dla ka\u017cdej metody, aby zapewni\u0107 poprawno\u015bc konceptu oraz wiarygodno\u015b\u0107 uzyskanych wynik\u00f3w. Po ustaleniu ostatecznych parametr\u00f3w dla metod zaplanowana zostanie analiza do 10 pr\u00f3bek.\n\n\nThe assessment of ADCC, ADCP, and CDC activities for a monoclonal antibody\u2014confirming the lack of Fc-effector functions.\nThe objective of this order is to develop state-of-the-art analytical methods for assessing the specified activities, with properly selected positive controls for each method to ensure proper design and reliability of the obtained results. Once the final methods setups are established, the analysis of up to 10 samples will be scheduled.\n","warranty_period":null,"cpv_items":[{"id":8513,"code":"73100000-3","name":"Us\u0142ugi badawcze i eksperymentalno-rozwojowe"}],"timetable_items":[],"fulfillment_places":[{"country":"Polska","voivodeship":"pomorskie","poviat":"Gda\u0144sk","commune":"Gda\u0144sk","locality":"Gda\u0144sk","created_by":null,"created_at":"2025-04-24 14:40:14","modified_at":"2025-04-24 14:54:25","modified_by":null,"id":615660,"type":{"id":1,"name":"adres"},"group_uuid":"7edc3d57-3c78-4f3b-926c-9b3b1543ee58"}],"participation_conditions":[{"id":1522332,"description":"Szczeg\u00f3\u0142owy opis warunk\u00f3w znajduje si\u0119 w Za\u0142\u0105czniku nr 1 / A detailed description\ncriteria in English can be found in Appendix 1A","type":{"id":4,"name":"Osoby zdolne do wykonania zam\u00f3wienia"},"created_by":null,"created_at":"2025-04-24 14:40:14","modified_at":"2025-04-24 14:54:25","modified_by":null,"group_uuid":"224ae890-0a0a-4d99-8d99-aefd1eabe5b1"}],"category":{"id":1,"name":"Us\u0142uga"},"subcategory":{"id":8,"name":"Us\u0142ugi inne"},"created_by":null,"created_at":"2025-04-24 14:40:14","modified_at":"2025-04-24 14:54:25","modified_by":null,"group_uuid":"6e61f584-f0c6-488e-a57e-0c289920b07e"}],"evaluation_criteria":[{"id":852478,"price_criterion":true,"description":"Cena - 70% \nSzczeg\u00f3\u0142owy opis kryterium oceny ofert znajduje si\u0119 w Za\u0142\u0105czniku nr 1 / A detailed description of the offer evaluation criteria in English can be found in Appendix 1A","created_by":null,"created_at":"2025-04-24 14:40:14","modified_at":"2025-04-24 14:54:25","modified_by":null,"group_uuid":"e8bbf5cd-0dd4-4b6d-ad3d-887c21320671"},{"id":852479,"price_criterion":false,"description":"Czas dostawy - 30%\nSzczeg\u00f3\u0142owy opis kryterium oceny ofert znajduje si\u0119 w Za\u0142\u0105czniku nr 1 / A detailed description of the offer evaluation criteria in English can be found in Appendix 1A","created_by":null,"created_at":"2025-04-24 14:40:14","modified_at":"2025-04-24 14:54:25","modified_by":null,"group_uuid":"c51830aa-289a-4b64-8b61-78929271114d"}],"is_variant":false,"title":"Zakup i dostawa us\u0142ugi / Purchase and delivery of service","order_node":{"id":366130},"created_by":null,"created_at":"2025-04-24 14:40:14","modified_at":"2025-04-24 14:54:25","modified_by":null}],"created_by":{"id":377,"contact_persons":[]},"modified_by":{"modified_by":null,"id":1,"contact_persons":[]},"status":{"id":2,"label":"PUBLISHED","name":"Opublikowane"},"advertiser_address_details":{"name":"Polpharma Biologics S.A.","identification_number_type":"nip","identification_number":"9571112470","address":{"country":"Polska","voivodeship":"pomorskie","poviat":"Gda\u0144sk","commune":"Gda\u0144sk","locality":"Gda\u0144sk","created_by":{"id":377,"contact_persons":[]},"created_at":"2025-04-24 14:40:14","modified_at":"2025-04-24 14:40:14","modified_by":{"id":377,"contact_persons":[]},"id":826979,"street":"Trzy Lipy ","number_description":"3","postcode":"80-172"},"created_by":{"id":377,"contact_persons":[]},"created_at":"2025-04-24 14:40:14","modified_at":"2025-04-24 14:40:14","modified_by":{"id":377,"contact_persons":[]},"id":298605},"advertisement":{"id":226030,"number":"2025-377-226030","publication_date":"2025-04-24","created_by":{"id":377,"contact_persons":[]},"created_at":"2025-04-24 14:40:14","modified_at":"2025-05-06 00:00:09","modified_by":{"modified_by":null,"id":1,"contact_persons":[]},"status":{"id":6,"label":"RESOLVED","name":"Rozstrzygni\u0119te"},"all_available_version_ids":[297800],"enrollment":null,"projects":[{"id":46637,"name":"Opracowanie innowacyjnej postaci leku zawieraj\u0105cego przeciwcia\u0142o monoklonalne do stosowania w leczeniu nieswoistych stan\u00f3w zapalnych jelit \u2013 II faza","number":"1014/23","activity":{"created_by":{"modified_by":null,"id":89,"contact_persons":[]},"created_at":"2023-02-01 09:22:25","modified_at":"2023-02-01 09:22:25","modified_by":{"modified_by":null,"id":89,"contact_persons":[]}},"region":null,"institution":{"created_by":{"modified_by":null,"id":89,"contact_persons":[]},"created_at":"2023-02-01 09:27:55","modified_at":"2023-02-01 09:27:55","modified_by":{"modified_by":null,"id":89,"contact_persons":[]}},"full_number":"FENG.01.01-IP.01-1014/23","perspective":{},"programme":{"created_by":{"modified_by":null,"id":89,"contact_persons":[]},"created_at":"2023-02-01 09:21:41","modified_at":"2023-02-01 09:21:41","modified_by":{"modified_by":null,"id":89,"contact_persons":[]}},"priority":{"created_by":{"modified_by":null,"id":89,"contact_persons":[]},"created_at":"2023-02-01 09:21:51","modified_at":"2023-02-01 09:21:51","modified_by":{"modified_by":null,"id":89,"contact_persons":[]}},"type":"project","created_by":{"id":377,"contact_persons":[]},"created_at":"2024-06-06 09:35:19","modified_at":"2024-06-06 09:35:19","modified_by":{"id":377,"contact_persons":[]}}],"is_author":false,"is_admin":false},"attachments":[{"origin":{"id":297800,"publication_date":"2025-04-24"},"id":1795606,"name":"Za\u0142\u0105cznik 1 Tre\u015b\u0107 zapytania ofertowego","file":{"id":1999106,"name":"Za\u0142\u0105cznik Nr 1 Tre\u015b\u0107 zapytania ofertowego.pdf","created_at":"2025-04-24 14:51:32","created_by":{"forename":"Gra\u017cyna","surname":"G\u00f3ra"},"uri":"/api/files/1999106"},"group_uuid":"b181dd7e-fcfb-4261-9ab9-f851517f1805"},{"origin":{"id":297800,"publication_date":"2025-04-24"},"id":1795607,"name":"Za\u0142\u0105cznik nr 2 O\u015bwiadczenie o braku powi\u0105za\u0144","file":{"id":1999107,"name":"Za\u0142\u0105cznik Nr 2 - O\u015bwiadczenie o braku powi\u0105za\u0144.pdf","created_at":"2025-04-24 14:51:47","created_by":{"forename":"Gra\u017cyna","surname":"G\u00f3ra"},"uri":"/api/files/1999107"},"group_uuid":"8f960fac-e2ea-4841-af5a-d637f82a3e8f"},{"origin":{"id":297800,"publication_date":"2025-04-24"},"id":1795608,"name":"Za\u0142\u0105cznik nr 4 O\u015bwiadczenie o spe\u0142nieniu warunk\u00f3w oferty","file":{"id":1999110,"name":"Za\u0142\u0105cznik Nr 4 O\u015bwiadczenie o spe\u0142nieniu warunk\u00f3w oferty.pdf","created_at":"2025-04-24 14:52:00","created_by":{"forename":"Gra\u017cyna","surname":"G\u00f3ra"},"uri":"/api/files/1999110"},"group_uuid":"9aa70d7f-69ac-4e50-8970-c2f202388308"},{"origin":{"id":297800,"publication_date":"2025-04-24"},"id":1795609,"name":"Appendix No 1A Content of the request for quotation","file":{"id":1999112,"name":"Appendix No 1A - Content of the request for quotation.pdf","created_at":"2025-04-24 14:52:11","created_by":{"forename":"Gra\u017cyna","surname":"G\u00f3ra"},"uri":"/api/files/1999112"},"group_uuid":"100df907-1598-4a40-84c3-865f3c11fae0"},{"origin":{"id":297800,"publication_date":"2025-04-24"},"id":1795610,"name":"Appendix No 2A Statement of non-affiliation with confirmation","file":{"id":1999116,"name":"Appendix Nr 2A -  Statement of Non-Affiliation with confirmation.pdf","created_at":"2025-04-24 14:52:23","created_by":{"forename":"Gra\u017cyna","surname":"G\u00f3ra"},"uri":"/api/files/1999116"},"group_uuid":"43bf0579-67f0-46a0-ae20-25d9d72239a1"},{"origin":{"id":297800,"publication_date":"2025-04-24"},"id":1795611,"name":"Appendix No 4A Statement on the fulfillment of the offer conditions","file":{"id":1999117,"name":"Appendix No 4A Statement on the fulfillment of the conditions of the offer.pdf","created_at":"2025-04-24 14:52:34","created_by":{"forename":"Gra\u017cyna","surname":"G\u00f3ra"},"uri":"/api/files/1999117"},"group_uuid":"96f0d5ac-eede-4a72-9e3a-c1693cbf5cff"}]},"dictionaries":{"announcement_status_draft":1,"announcement_status_published":2},"favorite":null,"badge":null,"offer_set_badge_count":null,"question_badge_count":null}}